A prospective planned pathology study within the TEAM trial confirms that progesterone receptor expression is prognostic but not predictive for differential response to exemestane versus tamoxifen.

Bartlett, J., Brookes, C., Billingham, L., Campell, F., Gnant, M., Hasenburg, A., Hille, E., Kay, C., Kieback, D., Markopoulos, C., Meershok-Klein Kranenberg, E., Mallon, E., Paridaens, R., Putter, H., Robson, T., Seynaeve, C., van de Velde and D Rea, C., 2008.

Cancer Res 69 (2 Supplement), 81. doi:10.1158/0008-5472.SABCS-81

Abstract